---
$id: https://graph.org.ai/products/commodity/51311802
$type: Product
source: UNSPSC
code: "51311802"
title: "Bilastine"
class: "51311800"
classTitle: "Antihistamine or H1 blocker benzimidazoles"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bilastine

**UNSPSC Code**: 51311802
**Class**: [Antihistamine or H1 blocker benzimidazoles](Antihistamine or H1 blocker benzimidazoles.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PA1123N395. European Medicines Agency schedules Bilastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37845. Bilastine generally arises in the molecular formula C28H37N3O3. The term BILASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 3, 2000, list 44.) Most nations schedule bilastine under HS 29333999 and SITC 51574. As of Q4 2014, BILASTINE remains the US FDA Preferred Term for this commodity. Bilastine bears US NLM identifiers UMLS ID C1101148 and NCI Concept Code C73045. SMILES: O(CCN1C(NC2C1CCCC2)C1CCN(CC1)CCC1CCC(C(C)(C)C(=O)O)CC1)CC.

